Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients

BACKGROUND: Butyrylcholinesterase (BChE) is synthesized mainly in the liver and an important marker in many infectious/inflammatory diseases, but its role in acquired immunodeficiency syndrome (AIDS) patients is not clear. We wished to ascertain if BChE level is associated with the progression/progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lijun, Zhu, Biao, Huang, Ying, Yang, Zongxing, Sun, Jia, Xu, Yan, Zheng, Jinlei, Kinloch, Sabine, Yin, Michael T., Weng, Honglei, Wu, Nanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875035/
https://www.ncbi.nlm.nih.gov/pubmed/29736152
http://dx.doi.org/10.1155/2018/5201652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875035/
https://www.ncbi.nlm.nih.gov/pubmed/29736152
http://dx.doi.org/10.1155/2018/5201652

Ejemplares similares